Pharmaceutical industry in China (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pharmaceutical industry in China" in English language version.

refsWebsite

Global rank English rank

9web.archive.org

1^st place

1^st place

low place

low place

low place

low place

4^th place

4^th place

447^th place

338^th place

low place

low place

1chinadaily.com.cn

831^st place

730^th place

1worldwatch.org

low place

low place

210^th place

157^th place

low place

low place

18^th place

17^th place

2^nd place

2^nd place

5^th place

5^th place

1qyresearchreports.com

low place

low place

low place

low place

7,882^nd place

low place

343^rd place

927^th place

low place

low place

low place

low place

low place

low place

1fiercepharma.com

low place

8,921^st place

1astrazeneca.com.cn

low place

low place

1researchandmarkets.com

low place

low place

163^rd place

185^th place

1allianceboots.com

low place

low place

allianceboots.com

Alliance Boots to enter Chinese pharmaceutical market through joint venture Archived 12 October 2007 at the Wayback Machine 29 January 2007

astrazeneca.com.cn

en.astrazeneca.com.cn

"AstraZeneca in China". Archived from the original on 19 December 2007.

bajunfund.com

"网站访问报错". bajunfund.com. Archived from the original on 27 March 2017. Retrieved 27 March 2017.

bizvibe.com

blog.bizvibe.com

"Top 10 Pharmaceutical Companies in China (2018)". 21 July 2017.

chinadaily.com.cn

于小明. "Fast growth in China's pharmaceutical market to benefit foreign firms: report – Chinadaily.com.cn". chinadaily.com.cn. Retrieved 14 January 2020.

cpa.org.cn

staff, 中国药学会 >> 中国药学会联系方式, cpa.org.cn (in Chinese), Chinese Pharmaceutical Association, archived from the original on 4 December 2010, retrieved 3 January 2012

doi.org

Yang, Caijun; Wu, Lina; Cai, Wenfang; Zhu, Wenwen; Shen, Qian; Li, Zongjie; Fang, Yu (25 October 2016). "Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study". PLOS ONE. 11 (10): e0165183. Bibcode:2016PLoSO..1165183Y. doi:10.1371/journal.pone.0165183. ISSN 1932-6203. PMC 5079602. PMID 27780218.

fda.gov

fda.gov

"Warning Letters". fda.gov. Retrieved 25 June 2018.

accessdata.fda.gov

"Import Alert Industry Group Human Drug". accessdata.fda.gov. Retrieved 25 June 2018.

fiercepharma.com

"China's Jiangsu Hengrui in R&D effort with MD Anderson – FiercePharma". fiercepharma.com. 4 May 2016.

ft.com

Dyer, Geoff (5 November 2006), "Novartis to open Shanghai research arm", Financial Times, retrieved 3 January 2012 ← No-charge registration required to reach this content.

google.com

"IMS: China to be 3rd largest pharma market in 2011", Google News, Associated Press, 16 March 2010, archived from the original on 24 March 2010, retrieved 3 January 2012

harvard.edu

ui.adsabs.harvard.edu

Yang, Caijun; Wu, Lina; Cai, Wenfang; Zhu, Wenwen; Shen, Qian; Li, Zongjie; Fang, Yu (25 October 2016). "Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study". PLOS ONE. 11 (10): e0165183. Bibcode:2016PLoSO..1165183Y. doi:10.1371/journal.pone.0165183. ISSN 1932-6203. PMC 5079602. PMID 27780218.

hrs.com.cn

"江苏恒瑞医药". Archived from the original on 30 August 2016. Retrieved 27 March 2017.
"江苏恒瑞". Archived from the original on 9 December 2016. Retrieved 27 March 2017.

hrssd.com.cn

"成都盛迪医药有限公司 – 成都盛迪医药有限公司". Hrssd.com.cn. Retrieved 25 June 2018.

incyte.com

"Archived copy". Archived from the original on 21 June 2016. Retrieved 27 March 2017.{{cite web}}: CS1 maint: archived copy as title (link)

jiemian.com

"医药上市公司去年研发花了多少钱？恒瑞医药近12亿当上创新领头羊|界面新闻 · 证券". Jiemian.com. 21 March 2017. Retrieved 25 June 2018.

nih.gov

ncbi.nlm.nih.gov

Yang, Caijun; Wu, Lina; Cai, Wenfang; Zhu, Wenwen; Shen, Qian; Li, Zongjie; Fang, Yu (25 October 2016). "Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study". PLOS ONE. 11 (10): e0165183. Bibcode:2016PLoSO..1165183Y. doi:10.1371/journal.pone.0165183. ISSN 1932-6203. PMC 5079602. PMID 27780218.

pubmed.ncbi.nlm.nih.gov

Yang, Caijun; Wu, Lina; Cai, Wenfang; Zhu, Wenwen; Shen, Qian; Li, Zongjie; Fang, Yu (25 October 2016). "Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study". PLOS ONE. 11 (10): e0165183. Bibcode:2016PLoSO..1165183Y. doi:10.1371/journal.pone.0165183. ISSN 1932-6203. PMC 5079602. PMID 27780218.

pmlive.com

"GSK betting on China's healthcare growth". PMLiVE. 13 March 2012. Retrieved 24 May 2012.
"Bayer expands research deal with university in China". PMLiVE. 28 March 2012. Retrieved 24 May 2012.
"BMS signs cardiovascular research deal with China's Simcere". PMLiVE. 14 December 2011.
"Merck pledges $1.5bn for China expansion". PMLiVE. 6 December 2011.
"Lilly extends contract with Chinese CRO ShangPharma". PMLiVE. 11 January 2012. Retrieved 24 May 2012.

qyresearchreports.com

"China Pharmaceutical Equipment Industry 2015 Market Research Report – QY Research".

researchandmarkets.com

ltd, Research and Markets. "Asian Animation, VFX & Games Industry: Strategies, Trends & Opportunities, 2018". researchandmarkets.com.

sohu.com

mt.sohu.com

"上市药企研发投入50强,有你家吗?". mt.sohu.com. 14 July 2016.

tesarobio.com

ir.tesarobio.com

"Tesaro and Jiangsu Hengrui Medicine Announce Rolapitant License Agreement for China (NASDAQ:TSRO)". Archived from the original on 27 March 2017. Retrieved 27 March 2017.

web.archive.org

staff, 中国药学会 >> 中国药学会联系方式, cpa.org.cn (in Chinese), Chinese Pharmaceutical Association, archived from the original on 4 December 2010, retrieved 3 January 2012
"江苏恒瑞医药". Archived from the original on 30 August 2016. Retrieved 27 March 2017.
"网站访问报错". bajunfund.com. Archived from the original on 27 March 2017. Retrieved 27 March 2017.
"江苏恒瑞". Archived from the original on 9 December 2016. Retrieved 27 March 2017.
"Archived copy". Archived from the original on 21 June 2016. Retrieved 27 March 2017.{{cite web}}: CS1 maint: archived copy as title (link)
"Tesaro and Jiangsu Hengrui Medicine Announce Rolapitant License Agreement for China (NASDAQ:TSRO)". Archived from the original on 27 March 2017. Retrieved 27 March 2017.
"AstraZeneca in China". Archived from the original on 19 December 2007.
"IMS: China to be 3rd largest pharma market in 2011", Google News, Associated Press, 16 March 2010, archived from the original on 24 March 2010, retrieved 3 January 2012
Alliance Boots to enter Chinese pharmaceutical market through joint venture Archived 12 October 2007 at the Wayback Machine 29 January 2007

worldcat.org

search.worldcat.org

Yang, Caijun; Wu, Lina; Cai, Wenfang; Zhu, Wenwen; Shen, Qian; Li, Zongjie; Fang, Yu (25 October 2016). "Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study". PLOS ONE. 11 (10): e0165183. Bibcode:2016PLoSO..1165183Y. doi:10.1371/journal.pone.0165183. ISSN 1932-6203. PMC 5079602. PMID 27780218.

worldwatch.org

"China's Pharmaceutical Industry Lacks Innovation, Lags Behind", China Watch, Washington, D.C., United States: Worldwatch Institute, worldwatch.org, retrieved 3 January 2012